With reference to mail Ref No. L/SURV/ONL/PV/MG/2023-2024/3272 dated 20th April 2023, IOL Chemicals & Pharmaceuticals has submitted that there is no such announcement or price sensitive information, which is pending to be intimated by the Company to the Stock Exchange that have a bearing on the operation /performance of the Company. The Company has further informed and clarified that all the information furnished by the Company is in public domain and Company will keep the Stock Exchanges duly informed of all the price sensitive information(s) in compliance with SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
